Introduction Transforming care Investing in our people Accelerating possibilities Protecting the environment Creating value responsibly Appendix Small and diverse suppliers Our approach to supplier selection builds diversity, equity and Change that makes ESG and business sense: inclusion throughout the Boston Scientific supplier network. Ideal product flow In the United States, we make it a priority to work with certified companies that share our values and commitment to customer As we continue to align business operations with our ESG priorities, we and patient care, including businesses that are minority-owned, are introducing a new process for ideal end-to-end product flow, including women-owned, small or disadvantaged, service-disabled, improving the way our products are sourced, manufactured, packaged, veteran-owned, LGBTQ+-owned and disability-owned. shipped and distributed. This new approach allows us to manufacture more products and reliably deliver them to customers and their patients, while making our supply chain more sustainable by lowering carbon emissions, reducing packaging waste and significantly decreasing our global shipping footprint. These advances will result in part from postponing product packaging until we determine the product’s destination. Where possible, products Supporting supplier diversity will be directly shipped to customers, skipping unnecessary handling and travel to and from distribution centers. For products headed to countries ~1,300 where regulations allow downloadable Instructions for Use (IFUs), we are eliminating paper IFUs and shipping devices more fuel efficiently in lighter small and diverse suppliers engaged packaging. Where printed IFUs are required, we only send instructions in $340+ million local languages rather than in multiple-language packets. In addition to reducing packaging waste and shipping weight, we are spent on small and diverse suppliers optimizing shipping routes. When feasible, we are transporting freight by sea rather than air to produce fewer emissions. By 2026, these changes Reduce paper Increase direct shipping Reduce supply chain are expected to: IFUs by to destination regions to costs annually by up to ~90% ~90% ~$80 million 53 2022 Performance Report
Advancing Science for Life | Boston Scientific Page 52 Page 54